We are live on ! Find out more
MA

MYDA Advisors Portfolio holdings

AUM $608M
1-Year Est. Return 77.08%
This Fund
S&P 500
This Quarter Est. Return
+60.81%
1 Year Est. Return
+77.08%
3 Year Est. Return
+189.24%
5 Year Est. Return
+248.06%
10 Year Est. Return
AUM
$229M
AUM Growth
+$82M
Cap. Flow
+$62.1M
Cap. Flow %
27.18%
Top 10 Hldgs %
33.64%
Holding
223
New
111
Increased
17
Reduced
12
Closed
82

Sector Composition

Rank Sector Weight
1 Communication Services 12.79%
2 Technology 10.81%
3 Consumer Discretionary 6.44%
4 Financials 4.73%
5 Real Estate 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBB
101
DELISTED
Cincinnati Bell Inc.
CBB
$393K 0.17%
+25,000
New +$366K
ONC
102
BeOne Medicines Ltd
ONC
$32.4B
$384K 0.17%
+2,500
New +$446K
MRKR icon
103
Marker Therapeutics
MRKR
$21.8M
$375K 0.16%
+3,980
New +$203K
MTG icon
104
MGIC Investment
MTG
$6.23B
$375K 0.16%
+35,000
New +$381K
TTD icon
105
Trade Desk
TTD
$8.74B
$375K 0.16%
+40,000
New +$282K
VATE icon
106
INNOVATE Corp
VATE
$123M
$366K 0.16%
+6,250
New +$367K
GBT
107
DELISTED
Global Blood Therapeutics, Inc.
GBT
$362K 0.16%
+8,000
New +$364K
TCDA
108
DELISTED
Tricida, Inc. Common Stock
TCDA
$359K 0.16%
+12,000
New +$335K
HRTX icon
109
Heron Therapeutics
HRTX
$89.1M
$354K 0.15%
+9,109
New +$290K
VNCE icon
110
Vince Holding Corp
VNCE
$82.7M
$330K 0.14%
+20,000
New +$215K
CISN
111
DELISTED
Cision Ltd. Ordinary Share
CISN
$299K 0.13%
+20,000
New +$281K
ZOES
112
CALL
DELISTED
Zoe's Kitchen, Inc.
ZOES
$294K 0.13%
+30,100
New +$382K
GWPH
113
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$279K 0.12%
+2,000
New +$284K
SRNE
114
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$252K 0.11%
+35,000
New +$238K
RTX icon
115
RTX Corp
RTX
$261B
$250K 0.11%
3,178
-7,508
-70% -$588K
SPNT icon
116
SiriusPoint
SPNT
$2.93B
$250K 0.11%
+20,000
New +$267K
GDP
117
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$247K 0.11%
+20,000
New +$254K
BV icon
118
BrightView Holdings
BV
$1.35B
$234K 0.1%
+10,650
New +$231K
NIHD
119
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$233K 0.1%
59,859
+39,859
+199% +$109K
KZR
120
DELISTED
Kezar Life Sciences
KZR
$213K 0.09%
+1,230
New +$215K
CARM
121
DELISTED
Carisma Therapeutics
CARM
$195K 0.09%
+5,000
New +$220K
ASLN
122
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$195K 0.09%
+548
New +$170K
MDXG icon
123
PUT
MiMedx Group
MDXG
$640M
$192K 0.08%
+30,000
New +$214K
SENS icon
124
Senseonics Holdings Inc
SENS
$267M
$170K 0.07%
+2,070
New +$148K
BVH
125
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$163K 0.07%
+3,600
New +$166K

Similar funds

MYDA Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, MYDA Advisors held 223 positions worth $229M, up 56% from $147M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

MYDA Advisors deployed $62.1M of net new capital in Q2 2018, opening 111 new positions and adding to 17 existing holdings. Its largest new stake was State Street Consumer Staples Select Sector SPDR ETF: 140,000 shares worth $7.21M.

By sector, the portfolio is most concentrated in Communication Services at 13% of assets, up from 6.4% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Kennedy-Wilson Holdings, an estimated $2.35M trimmed.

  • MYDA Advisors's largest Q2 2018 buy was State Street Consumer Staples Select Sector SPDR ETF: 140,000 shares worth $7.21M.
  • MYDA Advisors added most to Activision Blizzard in Q2 2018, an estimated $2.55M increase.
  • MYDA Advisors's biggest Q2 2018 reduction was Kennedy-Wilson Holdings, cutting an estimated $2.35M.
  • MYDA Advisors fully exited Booking.com in Q2 2018, selling an estimated $6.87M.
  • MYDA Advisors's ten largest holdings make up 34% of its $229M portfolio in Q2 2018.
  • MYDA Advisors opened 111 new positions and closed 82 in Q2 2018.
  • MYDA Advisors's portfolio value rose 56% quarter-over-quarter to $229M.

Based on MYDA Advisors's 13F filing for Q2 2018, filed 13 Aug 2018.